Monday, June 5, 2017
- 1:45pm-3:15pm
-
UPDRS III score and RS latency can determine the possible neuromodulative role of STN DBS in Parkinson’s disease (PD) patients
Surgical Therapy: Parkinson’s Disease · Exhibit Hall C
- 1:45pm-3:15pm
-
Use of pimavanserin in patients with Parkinson’s disease psychosis: Subgroup analysis of efficacy and safety in patients with and without cognitive impairment
Parkinson's Disease: Non-Motor Symptoms · Exhibit Hall C
- 1:45pm-3:15pm
-
Use of the Neuropsychiatric Inventory to Characterize the Course of Neuropsychiatric Symptoms in Progressive Supranuclear Palsy
Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus) · Exhibit Hall C
- 1:45pm-3:15pm
-
Utility of THK-5351 tau-PET for differential diagnosis in patients with hypokinetic-rigid syndromes.
Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus) · Exhibit Hall C
- 1:45pm-3:15pm
-
Validation of the performance based Erlangen Test of Activities of Daily Living in PD
Parkinson's Disease: Non-Motor Symptoms · Exhibit Hall C
- 1:45pm-3:15pm
-
Validation of the Utility of Brief Smell Identification Test Simplified Chinese Version 2 in Chinese Parkinson’s disease
Parkinson's Disease: Non-Motor Symptoms · Exhibit Hall C
- 1:45pm-3:15pm
-
Vascular Parkinsonism, an underdiagnosed Parkinsonian variant : An outpatient study from a South Indian Superspeciality Private Hospital
Epidemiology · Exhibit Hall C
- 1:45pm-3:15pm
-
Videoendoscopy study of swallowing in Parkinson’s disease
Parkinson's Disease: Non-Motor Symptoms · Exhibit Hall C